Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2024-03-20 Annual Report
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Annual Report 2023
Annual Report Classification · 100% confidence The document is titled 'Annual report for the year ended 31 December 2023' for Pharma Equity Group A/S. It contains a comprehensive table of contents, financial statements (consolidated and parent company), independent auditor's report, management review, and business outlook. It is clearly the full annual report, not an announcement or summary. FY 2023
2024-03-20 English
Annual Report 2023
Annual Report Classification · 100% confidence The document is titled 'Annual report for the year ended 31 December 2023' for Pharma Equity Group A/S. It contains a comprehensive table of contents, financial statements (consolidated and parent company), independent auditor's report, management review, and business outlook. It is clearly the full annual report, not an announcement or summary. FY 2023
2024-03-20 English
Pharma Equity Group A/S - Annual Report 2023
Annual Report Classification · 95% confidence The document is titled 'Årsrapport 2023' (Annual Report 2023) and provides a summary of the company's financial performance, including the annual result, research and development costs, equity, and future strategy. While it acts as a summary of the annual report, it contains substantive financial data and analysis for the full fiscal year. According to the 'Menu vs Meal' rule, although it is an announcement, it provides the core financial highlights and results of the annual report rather than just a link to a separate document, making it a primary financial disclosure for the period. FY 2023
2024-03-20 Danish
Pharma Equity Group A/S - Annual Report 2023
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 6,200 characters) from Pharma Equity Group A/S regarding the publication of their 2023 Annual Report. It summarizes key financial highlights and provides links to download the actual report files ('Vedhæftede filer'). According to the 'Menu vs Meal' rule, since this is an announcement of a report rather than the full report itself, it is classified as a Report Publication Announcement (RPA).
2024-03-20 Danish
Pharma Equity Group A/S - Annual Report 2023
Report Publication Announcement Classification · 95% confidence The document is an announcement from Pharma Equity Group A/S regarding their 2023 Annual Report. While it contains financial highlights and management commentary, it is clearly an 'Announcement of the Year' (No. 7) serving as a summary and notification that the full annual report has been approved and is available. Per the 'Menu vs Meal' rule, this is a report publication announcement rather than the full 10-K/Annual Report document itself. FY 2023
2024-03-20 English
Pharma Equity Group A/S - Annual Report 2023
Report Publication Announcement Classification · 100% confidence The document is a short announcement (approx. 6,500 characters) from Pharma Equity Group A/S regarding the release of their 2023 Annual Report. It summarizes key financial highlights and provides links to download the actual annual report and the announcement itself. Per the 'Menu vs Meal' rule, since this is an announcement of a report rather than the full report itself, it is classified as a Report Publication Announcement (RPA).
2024-03-20 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.